A study in which IrsiCaixa has participated shows that the anticancer drug dasatinib, in combination with antiretroviral treatment, reduces the reactivation ability and the size of the viral reservoir...
Read moreIn this video you can watch the course organised by the Chair in Infectious Diseases and Immunity UVIC-UCC, directed by Dr Clotet, in which all the information related to HIV infection and the COVID-1...
Read moreThe HTI vaccine of AELIX Therapeutics, a spin-off of HIVACAT, shows in a Phase I/IIa clinical trial that 40% of the participants who received the vaccine have better control of the virus when the trea...
Read moreToday is World AIDS Day and we would like to take this opportunity to increase the awareness on this disease and to thank everyone working tirelessly to end AIDS.
Read moreThe IrsiCaixa AIDS Research Institute celebrates its 25th anniversary as an international center of reference in the field of HIV and infectious diseases. The research at IrsiCaixa is now expanding to...
Read moreScientists led by Andreas Meyerhans and Gennady Bocharov have designed a mathematical model to predict the response of HIV-infected individuals to a type of cancer immunotherapy.
Read moreThe WHO Guideline Development Group decided to recomment dolutegravir as the preferred first-line and second-line treatment for all populations, in contrast with initial studies.
Read moreIn the future, a model of this kind will enable scientists to carry out computer experiments for the development of vaccines and medicines for infectious diseases. The study, led by Russian researcher...
Read moreThe study demonstrates that the receptor Siglec-1 is used by different virus, such as Ebola, Marburg and HIV, to enter the myeloid cells and develops novel antibodies against this protein.
Read moreThe discovery modifies how the problem of bone fracture is addressed in these patients, leading the way to studies of new drugs that complement treatments for combatting the virus
Read moreHow did we go from 270 reported cases of AIDS in the United States in 1981 to 37 million people living with HIV worldwide in 2017? What did we do right and what could we have done better?
Read moreThe article shows for the first time that stem cell source, time to achieve full replacement of recipient cells with donor cells and graft-versus-host reactivity might contribute to HIV eradication. T...
Read more